G73.3
BillableMyasthenic syndromes in other diseases classified elsewhere
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is G73.3 an HCC code?
Yes. G73.3 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre under the CMS-HCC V28 risk adjustment model (and Myasthenia Gravis/Myoneural Conditions and Guillain-Barre Syndrome under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G73.3
For G73.3 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G73.3 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
G73.3 is the ICD-10-CM diagnosis code for myasthenic syndromes in other diseases classified elsewhere. Myasthenic symptoms (muscle weakness and fatigue) that occur as a result of another disease classified elsewhere. The muscle weakness is secondary to another underlying condition. G73.3 sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering diseases of myoneural junction and muscle (g70-g73).
Under the CMS-HCC V28 risk adjustment model, G73.3 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre (HCC 196) with a community, non-dual, aged base RAF weight of 0.402. Under the older CMS-HCC V24 model, G73.3 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre Syndrome (HCC 75) with a community, non-dual, aged base RAF weight of 0.425. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
This code requires a secondary diagnosis code to identify the underlying disease causing the myasthenic symptoms. Because G73.3 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G73.3 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This code requires a secondary diagnosis code to identify the underlying disease causing the myasthenic symptoms
- •Do not use this code for primary myasthenia gravis; this is specifically for myasthenic symptoms secondary to other diseases
Clinical Significance
Myasthenic syndromes in other diseases classified elsewhere indicates that myasthenic symptoms (muscle weakness and fatigability) have developed secondary to another underlying condition. This manifestation code adds clinical complexity beyond the primary disease, showing that the patient has developed neuromuscular complications requiring additional management. Accurate coding reflects the multisystem nature of the patient's disease.
Documentation Requirements
- ✓Documentation of the underlying disease causing the myasthenic symptoms
- ✓The underlying disease code must be sequenced first (etiology before manifestation)
- ✓Clinical features of myasthenic syndrome: weakness, fatigability, pattern of involvement
- ✓Distinction from primary myasthenia gravis
- ✓Electrodiagnostic studies when available
- ✓Provider's explicit documentation linking the myasthenic symptoms to the underlying disease